The company bought Park Row in 2003 for £16.7m but the adviser firm posted losses of £5.8m last year despite cutting costs from £11.2m in 2007 to £7.9m in 2008.
Heavy hits to Park Row’s core mortgage and protection business, declining investor confidence and the loss of a number of registered advisers last year coupled with the economic downturn were blamed for the reduced group turnover.
A Royal Liver spokesman says: “We have received a number of enquiries about Park Row in recent months. The sector is changing rapidly and some are looking to enter or expand. We are considering our strategic options, which, as always, could range from withdrawal from the distribution space or could include adding to our presence, given that any operation needs scale in this sector.”
In March, Money Marketing revealed that Park Row was being investigated by the FSA as part of a review into its systems and controls.
Park Row says it continues to cooperate with the FSA on all matters relating to regul- atory controls and systems.
A spokesman for the firm says: “We are doing our utmost to ensure that we are beyond reproach on that front.”